Expanded designs that enable clinicians to leverage data in making healthcare decisions, but privacy challenges remain.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
The goal of the voluntary program is to streamline the submission process. The agency also announced that it has selected participants for its EtO Innovation Challenges.
The report also found that medical device companies are taking “huge gambles” in the area of risk management.
CooperVision, Inc. and Pentax of America won the agency approvals, respectively.
AdvaMed states that the huge tax increase will have a significant impact on employment and investment.
The number of recalls also increased 21.5% this quarter, according to Stericycle’s Q3 2019 Recall Index.
Stakeholders warn that more EtO facility closures could have a catastrophic result.
The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
The White House issued a statement on the president’s intent to nominate Hahn, who is currently the chief medical executive at The University of Texas MD Anderson Cancer Center in Houston.